[1] |
LI Junjie.
Progress and future prospects in local and systemic treatment of early breast cancer
[J]. China Oncology, 2025, 35(2): 205-212.
|
[2] |
LAN Yu, WANG Fenghua.
Comparison and review of updated guidelines for advanced gastric cancer diagnosis and treatment in 2024: CSCO, NCCN and ESMO
[J]. China Oncology, 2025, 35(2): 219-227.
|
[3] |
CAI Shuyue, XIE Quan, ZHOU Yuxuan, LIU Qingzhu, QIU Ling, LIN Jianguo.
Latest progress and prospect of NRP-1 targeted molecular probes for breast cancer diagnosis
[J]. China Oncology, 2025, 35(2): 249-254.
|
[4] |
ZHAO Yihan, LI Ruochen, LIN Yansong.
Current status and prospect of diagnosis and treatment of bone metastasis of thyroid cancer
[J]. China Oncology, 2025, 35(1): 12-20.
|
[5] |
WANG Renfei, LU Gaixia.
The unique value and controversy of nuclear medicine molecular imaging in the evaluation of radioiodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2025, 35(1): 49-57.
|
[6] |
Society of Neuroendocrine Neoplasm of China Anti-Cancer Association.
China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasms (2025 edition)
[J]. China Oncology, 2025, 35(1): 85-142.
|
[7] |
LIAO Ziyi, PENG Yang, ZENG Beilei, MA Yingying, ZENG Li, GAN Kelun, MA Daiyuan.
Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(7): 669-679.
|
[8] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
[9] |
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology .
Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition)
[J]. China Oncology, 2024, 34(5): 517-526.
|
[10] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[11] |
SHI Jialu, ZHU Tingting, TAO Xiang, MA Fenghua, LIN Zhi, SHAO Jun, ZHAO Yuqing.
Retrospective analysis of 12 cases of low grade extrauterine endometrial stromal sarcoma and literature review
[J]. China Oncology, 2024, 34(4): 418-424.
|
[12] |
XU Yonghu, XU Dazhi.
Progress and prospects of gastric cancer treatment in the 21st century
[J]. China Oncology, 2024, 34(3): 239-249.
|
[13] |
QU Guolun, ZHANG Ruming, CHEN Yong, QU Xinglong, ZHANG Hongqiang, WANG Hongbo, WANG Kangwei, PENG Shuai.
Surgical margin and efficacy evaluation of barrier resection for soft tissue sarcoma of extremities in 72 cases
[J]. China Oncology, 2024, 34(3): 293-298.
|
[14] |
Expert Committee on Pathology of Chinese Research Hospital Association , Professional Committee on Tumor Pathology of Shanghai Anticancer Association .
Practice guideline for the histopathological diagnosis of mesothelioma (2025 version)
[J]. China Oncology, 2024, 34(12): 1144-1163.
|
[15] |
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association .
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition)
[J]. China Oncology, 2024, 34(1): 13-66.
|